Andrew Evens, DO, MBA, MSc, shares insights from a study on improving prognostic accuracy for advanced-stage Hodgkin lymphoma. Continuous variable modeling such as the Hodgkin lymphoma international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results